Bipolar Depression Treatment: Why Antidepressants Alone Are Risky

You’ve felt low for weeks, maybe months. You finally see someone, and an antidepressant seems like the obvious next step. But if you’ve ever had stretches where you barely slept and still felt unstoppable, or your mind raced faster than you could talk, the usual depression playbook may not fit. Bipolar depression looks like ordinary depression from the inside, and the treatment that works for one can backfire in the other.

Your brain regulates mood across a range, from lows to highs. In bipolar disorder, that regulation can swing in both directions, so a medication that pushes mood upward can overshoot into hypomania or mania. Treating the low without destabilizing the high takes precision, and it starts with knowing which direction your mood can move.

For most depression, antidepressants are a well-supported first choice. In bipolar disorder, they’re still widely used, and researchers have tested them carefully. A large STEP-BD trial of 366 people with bipolar depression found that adding a standard antidepressant to a mood stabilizer didn’t cause more mood switches than placebo. The results are real, and the science is well established.

But that trial also found no extra benefit from the antidepressant, and at Siggy we think a medication that doesn’t add benefit shouldn’t be the default when a pattern of highs is part of your history.

That’s why treatment guidelines point toward medications studied specifically in bipolar depression, such as quetiapine, lurasidone, lamotrigine, and lithium, and newer trials support cariprazine as well. These options treat the low while respecting the risk of a high. The difference comes from clinical trial evidence, and it should shape what you’re offered first.

What This Page Covers

• What Makes Bipolar Depression Different?
• Why Are Antidepressants Alone Risky?
• What Medications Treat Bipolar Depression?
• How Do These Options Compare?
• Is There Still a Role for Antidepressants?
• What Warning Signs Should You Watch For?
• How Siggy Fits In
• The Bottom Line on Bipolar Depression Treatment
• Start Your Anonymous Intake

What Makes Bipolar Depression Different?

Bipolar depression is a depressive episode in someone who also has, or has had, episodes of mania or hypomania. The depressive symptoms can look identical to other depression: low mood, loss of interest, poor sleep, fatigue, and hopelessness.

What sets bipolar disorder apart is how much of it is spent depressed. In a long-term bipolar II study that followed 86 people for an average of 13.4 years, depressive symptoms were present in 50.3% of weeks, compared with hypomanic symptoms in 1.3%. That’s one reason bipolar disorder is easy to miss: the highs can be brief, mild, or even feel good, so people rarely mention them.

Our guide to bipolar depression vs. depression covers the clues that help tell them apart.

Why Are Antidepressants Alone Risky?

The main concern is a switch into mania or hypomania. In a Swedish registry study of 3,240 people with bipolar disorder starting an antidepressant, those taking an antidepressant alone had nearly three times the risk of mania in the first 3 months. People who took an antidepressant along with a mood stabilizer showed no increased risk. The same study found that almost 35% of patients were on antidepressant monotherapy anyway, and the authors noted that, at the time, no standard antidepressant had been approved as monotherapy for bipolar depression by U.S. or European regulators.

The benefit side is also weaker than many people assume. In the STEP-BD trial above, 23.5% of people taking a mood stabilizer plus an antidepressant reached durable recovery, compared with 27.3% taking a mood stabilizer plus placebo.

Those findings shaped expert guidance. An international expert group, the ISBD task force, concluded that people with bipolar I should take antidepressants only as an add-on to mood-stabilizing medication. The task force also reported that antidepressant-related mood elevations appear more common and more severe in bipolar I than in bipolar II.

What Medications Treat Bipolar Depression?

Several medications have been tested specifically in bipolar depression. The CANMAT 2018 guidelines list quetiapine, lurasidone alone or with lithium or valproate, lithium, and lamotrigine alone or as an add-on among first-line options for bipolar I depression.

Quetiapine

In the BOLDER quetiapine trial of 542 people with bipolar I or II depression, about 58% responded to quetiapine at 300 or 600 mg a day over 8 weeks, compared with 36% on placebo. Rates of mania were low and similar to placebo. Our guide to Seroquel side effects covers what to expect.

Lurasidone

In a lurasidone monotherapy trial in bipolar I depression, doses from 20 to 120 mg a day significantly reduced depressive symptoms compared with placebo, with few changes in weight or metabolic measures. Our guide to Latuda side effects has more detail.

Cariprazine

In a pivotal cariprazine trial, a phase 3 study of 480 adults with bipolar I depression, both 1.5 mg and 3 mg a day reduced depressive symptoms more than placebo over 6 weeks. The most common side effects included nausea, akathisia, which is an inner restlessness, dizziness, and sedation. Our guide to Vraylar side effects explains each one.

Lamotrigine

Lamotrigine’s strength is preventing future episodes. In two pooled 18-month maintenance trials, lamotrigine delayed the need for treatment of a new depressive episode compared with placebo. For acute depression, an individual patient meta-analysis of five trials found a modest overall benefit that was clear in more severe depression but not in milder cases.

Lamotrigine has to be started slowly. The Lamictal prescribing information notes that nearly all life-threatening rashes have appeared within 2 to 8 weeks of starting, and that exceeding the recommended starting dose or rate of increase may raise that risk. Our guide to Lamictal for bipolar walks through the titration.

Lithium

Lithium is one of the guideline first-line options for bipolar I depression, and the same guidelines list it as a first-line option for long-term maintenance. Our guide to lithium for bipolar covers how it works and the blood monitoring it requires.

How Do These Options Compare?

Here’s a quick comparison of the main options, based on the trials and guidelines above.

Medication	What Trials Found	2018 Guideline Status
Quetiapine	About 58% vs 36% response at 8 weeks	First-line
Lurasidone	Less depression at 20 to 120 mg a day	First-line, alone or added on
Cariprazine	Both tested doses beat placebo at 6 weeks	Not first-line for depression
Lamotrigine	Modest acute benefit, delays new depression	First-line
Antidepressant alone	Higher mania risk in registry data	Avoid in bipolar I

Each option has tradeoffs in side effects and monitoring, so the best choice depends on your history, your other health conditions, and what matters most to you.

Is There Still a Role for Antidepressants?

Antidepressants still have a limited role for some people. The ISBD task force didn’t rule them out: it acknowledged that individual patients may benefit, and for bipolar I it limited antidepressants to an add-on role.

The type of antidepressant may matter too. The task force reported that SSRIs and bupropion may carry lower rates of manic switch than tricyclic antidepressants and SNRIs. In practice, that means an antidepressant in bipolar disorder is usually an add-on decision made by a prescriber who knows your full mood history, not a starting point. Our guide to mood stabilizers explains the medications usually used as that foundation.

What Warning Signs Should You Watch For?

If you have bipolar disorder or think you might, watch for signs that mood is moving up, especially after starting or changing a medication:

• Needing much less sleep without feeling tired
• Racing thoughts or talking faster than usual
• Unusual irritability, agitation, or restlessness
• Big plans, spending sprees, or risky decisions that aren’t like you
• Feeling unusually confident or invincible

Call your prescriber promptly if these show up. Our guide to hypomania vs. mania explains how the two differ. If you’re having thoughts of suicide, call or text 988 to reach the Suicide and Crisis Lifeline. If you or someone else is in immediate danger, call 911.

How Siggy Fits In

Siggy’s licensed prescribers diagnose and treat the full range of mental health conditions, including bipolar disorder and depression. That’s exactly why the intake asks about your highs as carefully as your lows. Siggy’s intake gathers structured information rather than diagnosing you on its own, and a licensed prescriber reviews your full history, including any past mania, hypomania, or family history of bipolar disorder, before anything is prescribed.

“I have to retell my story every time I see someone new.” With mood disorders, the details that slip between visits are often the ones that matter most. If your history suggests bipolar disorder, an antidepressant alone isn’t the right starting point, and your downloadable summary is a useful thing to bring to a psychiatrist who treats bipolar disorder. The anonymous intake asks for no name, email, or account.

Siggy isn’t an emergency service. If you’re in crisis, call 911 or call or text 988. This article is for education only and isn’t a substitute for personal medical advice. It reflects sources available as of October 2026.

The Bottom Line on Bipolar Depression Treatment

Bipolar depression needs a different plan than ordinary depression. Antidepressants alone are linked to a higher risk of mania and haven’t shown clear added benefit, so guidelines favor medications studied specifically in bipolar depression, such as quetiapine, lurasidone, lamotrigine, and lithium, with cariprazine as another evidence-backed option. Antidepressants still have a limited, add-on role for some people. If you’re not sure whether your depression is bipolar, our guide to bipolar 1 vs. bipolar 2 is a good place to start.

Start Your Anonymous Intake

If you’re dealing with depression and want a careful look at your full mood history, including any highs, start your anonymous intake. It’s free, there’s no name or email required, and a licensed prescriber reviews your intake before anything is prescribed. Your summary is yours to keep and share with whoever helps you next.